Thus, we suggest that HDAC inhibitors are involved indirectly in Met and CXCR4 induction by controlling the activities of transcription factors with different mechanisms that possibly depended on carcinoma cell aggressiveness. This evidence concerns the gene HDAC9 and carcinoma.